» Articles » PMID: 25516092

Characteristics and Comprehensiveness of Adult HIV Care and Treatment Programmes in Asia-Pacific, Sub-Saharan Africa and the Americas: Results of a Site Assessment Conducted by the International Epidemiologic Databases to Evaluate AIDS (IeDEA)...

Abstract

Introduction: HIV care and treatment programmes worldwide are transforming as they push to deliver universal access to essential prevention, care and treatment services to persons living with HIV and their communities. The characteristics and capacity of these HIV programmes affect patient outcomes and quality of care. Despite the importance of ensuring optimal outcomes, few studies have addressed the capacity of HIV programmes to deliver comprehensive care. We sought to describe such capacity in HIV programmes in seven regions worldwide.

Methods: Staff from 128 sites in 41 countries participating in the International epidemiologic Databases to Evaluate AIDS completed a site survey from 2009 to 2010, including sites in the Asia-Pacific region (n=20), Latin America and the Caribbean (n=7), North America (n=7), Central Africa (n=12), East Africa (n=51), Southern Africa (n=16) and West Africa (n=15). We computed a measure of the comprehensiveness of care based on seven World Health Organization-recommended essential HIV services.

Results: Most sites reported serving urban (61%; region range (rr): 33-100%) and both adult and paediatric populations (77%; rr: 29-96%). Only 45% of HIV clinics that reported treating children had paediatricians on staff. As for the seven essential services, survey respondents reported that CD4+ cell count testing was available to all but one site, while tuberculosis (TB) screening and community outreach services were available in 80 and 72%, respectively. The remaining four essential services - nutritional support (82%), combination antiretroviral therapy adherence support (88%), prevention of mother-to-child transmission (PMTCT) (94%) and other prevention and clinical management services (97%) - were uniformly available. Approximately half (46%) of sites reported offering all seven services. Newer sites and sites in settings with low rankings on the UN Human Development Index (HDI), especially those in the President's Emergency Plan for AIDS Relief focus countries, tended to offer a more comprehensive array of essential services. HIV care programme characteristics and comprehensiveness varied according to the number of years the site had been in operation and the HDI of the site setting, with more recently established clinics in low-HDI settings reporting a more comprehensive array of available services. Survey respondents frequently identified contact tracing of patients, patient outreach, nutritional counselling, onsite viral load testing, universal TB screening and the provision of isoniazid preventive therapy as unavailable services.

Conclusions: This study serves as a baseline for on-going monitoring of the evolution of care delivery over time and lays the groundwork for evaluating HIV treatment outcomes in relation to site capacity for comprehensive care.

Citing Articles

HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre study (DTG RESIST).

Egger M, Sauermann M, Loosli T, Hossmann S, Riedo S, Beerenwinkel N BMJ Open. 2024; 14(8):e085819.

PMID: 39174068 PMC: 11340720. DOI: 10.1136/bmjopen-2024-085819.


Risk factors for toxoplasmosis in people living with HIV in the Asia-Pacific region.

Lee K, Jiamsakul A, Kiertiburanakul S, Borse R, Khol V, Yunihastuti E PLoS One. 2024; 19(7):e0306245.

PMID: 38950027 PMC: 11216616. DOI: 10.1371/journal.pone.0306245.


Preexposure prophylaxis availability among health facilities participating in the global International epidemiology Databases to Evaluate AIDS (IeDEA) consortium.

Kebede S, Brazier E, Freeman A, Muwonge T, Choi J, de Waal R AIDS. 2023; 38(5):751-756.

PMID: 38133656 PMC: 10939841. DOI: 10.1097/QAD.0000000000003824.


Integration of HIV care into maternal and child health services in the global IeDEA consortium.

Humphrey J, Nagel E, Carlucci J, Edmonds A, Kinikar A, Anderson K Front Glob Womens Health. 2023; 4:1066297.

PMID: 37139173 PMC: 10150067. DOI: 10.3389/fgwh.2023.1066297.


Design and implementation of a global site assessment survey among HIV clinics participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) research consortium.

Brazier E, Maruri F, Wester C, Musick B, Freeman A, Parcesepe A PLoS One. 2023; 18(3):e0268167.

PMID: 36917598 PMC: 10013879. DOI: 10.1371/journal.pone.0268167.


References
1.
Mills E, Nachega J, Buchan I, Orbinski J, Attaran A, Singh S . Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006; 296(6):679-90. DOI: 10.1001/jama.296.6.679. View

2.
Kitahata M, Tegger M, Wagner E, Holmes K . Comprehensive health care for people infected with HIV in developing countries. BMJ. 2002; 325(7370):954-7. PMC: 1124448. DOI: 10.1136/bmj.325.7370.954. View

3.
McGowan C, Cahn P, Gotuzzo E, Padgett D, Pape J, Wolff M . Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. Int J Epidemiol. 2007; 36(5):969-76. DOI: 10.1093/ije/dym073. View

4.
Keiser O, Anastos K, Schechter M, Balestre E, Myer L, Boulle A . Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Trop Med Int Health. 2008; 13(7):870-9. PMC: 3722496. DOI: 10.1111/j.1365-3156.2008.02078.x. View

5.
Brinkhof M, Dabis F, Myer L, Bangsberg D, Boulle A, Nash D . Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. 2008; 86(7):559-67. PMC: 2647487. DOI: 10.2471/blt.07.044248. View